Life sciences news
-
argenx reports topline results from ADDRESS study of efgartigimod SC in pemphigus
Wednesday December 20th 2023
Read more
-
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301
Wednesday December 20th 2023
Read more
-
Biotalys announces results of independent field trials in the U.S.
Tuesday December 19th 2023
Read more
-
Mithra receives positive DSMB Opinion on DONESTA® European Phase 3 Trial
Monday December 18th 2023
Read more
-
Sequana Medical announces positive data from non-randomized cohort in US Phase 1/2a MOJAVE study of DSR® 2.0 for treatment of heart failure
Wednesday November 29th 2023
Read more
-
argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia
Tuesday November 28th 2023
Read more
-
Orionis Biosciences announces first patient dosed in Phase 1 clinical trial of ORB-011 in patients with advanced solid tumors
Wednesday November 15th 2023
Read more
-
SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars
Tuesday November 14th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission
Thursday October 19th 2023
Read more
-
Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome
Wednesday October 18th 2023
Read more
-
Agomab raises $100 million Series C to advance fibrosis-focused pipeline
Wednesday October 11th 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
